skip to main
|
skip to sidebar
biosink
4.25.2007
Glaxo's Sales Drop as Patents Expire, Guides Upbeat - Seeking Alpha
"British drugmaker GlaxoSmithKline posted earnings little changed from last year on stunted sales growth of its asthma and diabetes treatments."
Newer Post
Older Post
Home
Blog Archive
►
2013
(14)
►
05/05 - 05/12
(1)
►
04/07 - 04/14
(9)
►
03/31 - 04/07
(1)
►
03/10 - 03/17
(3)
►
2010
(4)
►
06/13 - 06/20
(1)
►
01/31 - 02/07
(2)
►
01/10 - 01/17
(1)
►
2009
(22)
►
09/20 - 09/27
(2)
►
09/06 - 09/13
(1)
►
08/09 - 08/16
(1)
►
08/02 - 08/09
(1)
►
07/12 - 07/19
(1)
►
05/10 - 05/17
(2)
►
04/19 - 04/26
(5)
►
04/12 - 04/19
(1)
►
04/05 - 04/12
(7)
►
03/01 - 03/08
(1)
►
2008
(290)
►
12/28 - 01/04
(2)
►
12/21 - 12/28
(4)
►
12/14 - 12/21
(2)
►
11/23 - 11/30
(1)
►
10/26 - 11/02
(5)
►
10/19 - 10/26
(5)
►
10/12 - 10/19
(55)
►
10/05 - 10/12
(1)
►
09/28 - 10/05
(1)
►
09/21 - 09/28
(45)
►
09/14 - 09/21
(3)
►
08/31 - 09/07
(5)
►
08/24 - 08/31
(20)
►
08/17 - 08/24
(3)
►
08/10 - 08/17
(1)
►
08/03 - 08/10
(3)
►
07/13 - 07/20
(1)
►
07/06 - 07/13
(2)
►
06/29 - 07/06
(13)
►
06/15 - 06/22
(2)
►
06/08 - 06/15
(2)
►
06/01 - 06/08
(2)
►
05/25 - 06/01
(7)
►
05/18 - 05/25
(7)
►
05/11 - 05/18
(1)
►
04/27 - 05/04
(9)
►
04/20 - 04/27
(22)
►
04/13 - 04/20
(11)
►
04/06 - 04/13
(20)
►
03/30 - 04/06
(4)
►
03/23 - 03/30
(1)
►
03/16 - 03/23
(1)
►
03/09 - 03/16
(1)
►
02/24 - 03/02
(3)
►
02/17 - 02/24
(10)
►
02/10 - 02/17
(5)
►
02/03 - 02/10
(2)
►
01/27 - 02/03
(3)
►
01/13 - 01/20
(4)
►
01/06 - 01/13
(1)
▼
2007
(1218)
►
12/16 - 12/23
(4)
►
12/02 - 12/09
(5)
►
11/25 - 12/02
(4)
►
11/18 - 11/25
(22)
►
11/11 - 11/18
(31)
►
11/04 - 11/11
(10)
►
10/28 - 11/04
(4)
►
10/21 - 10/28
(15)
►
10/14 - 10/21
(31)
►
10/07 - 10/14
(85)
►
09/30 - 10/07
(129)
►
09/23 - 09/30
(23)
►
09/16 - 09/23
(98)
►
09/09 - 09/16
(116)
►
09/02 - 09/09
(52)
►
08/26 - 09/02
(57)
►
08/19 - 08/26
(52)
►
07/29 - 08/05
(40)
►
07/22 - 07/29
(173)
►
07/15 - 07/22
(24)
►
07/08 - 07/15
(10)
►
05/06 - 05/13
(7)
►
04/29 - 05/06
(76)
▼
04/22 - 04/29
(150)
BBC NEWS | UK | Scotland | Tayside and Central | S...
S.F. becomes biological choice / City's starting t...
Firms join on biotech
SSRN-Authorized Generics: A Prescription for Hatch...
Biotech contenders - baltimoresun.com
Variant Strain of Chlamydia May Go Undetected
Ranbaxy Receives Final Approval to Manufacture and...
Report Finds Massachusetts's Life Sciences Sector ...
Press Release: Report Finds Massachusetts's Life S...
Press Release: Spherix Signs Letter of Intent for ...
Human Genome Sciences Reports Growing Evidence Tha...
Researchers Discover First Gene Associated With Id...
LuBlog: Biotech to drive next wave of electronics ...
People's Daily Online -- Zambia continues to be ca...
PharmaLive: Cytos Biotechnology Enters Exclusive L...
Chinese AIDs Drug Set for Clinical Tests
CTV.ca | Canadian researchers 'create' leukemia st...
California Stem Cell Report: More Fallout from CIR...
Press Release: Cerus Corporation Considering Spinn...
Second look reveals potential for Columbia Labs dr...
Health Blog : Report: AstraZeneca Could Dump MedIm...
VentureBeat � Cellerant Therapeutics raises $4.4M ...
A Bearish Case for Amgen
Health Blog : Biogen Idec CEO Prescribes Policy Fixes
Health Blog : Mixed Picture for Boston Scientific
VentureBeat � Biotech financing: Not everyone gets...
GENE THERAPY | Daily Policy Digest | NCPA
Youth Curry - Insight on Indian Youth: 'Biotech bo...
Novartis says Japanese study shows Diovan reduces ...
PS3 doubles Folding@home capacity - FierceGameBiz
Novartis' influenza vaccine Optaflu recommended fo...
FDA sends Merck a Dear John letter on Arcoxia - Ap...
Hollis-Eden to Cut One-Fourth of Staff | Chron.com...
MPM strikes deal to invest in Indian biotechs - Fi...
Generics Challenge FDA's Decision On Pfizer Drug -...
Digital50: News and more Business News
Survey Suggests RFID Could Aid Clinical Trials
FDA Approves Once-Daily Veramyst(TM) (fluticasone ...
CQ HealthBeat News - Hatch May Soon Introduce Comp...
Health Blog : FDA Approves Magnum PI
AstraZeneca's MedImmune Acquisition Should Receive...
Science Journal (Almost) Polices the Blogosphere: ...
British drugmaker to buy MedImmune - baltimoresun.com
Lawmakers urges high tech, pharmaceutical industri...
Impact China Event in Shanghai to Highlight Burgeo...
California Healthcare Institute Submits Statement ...
Promote the Progress� ::: J. Matthew Buchanan's Pa...
Nanotechnology Offers Hope for Treating Spinal Cor...
Orange Book Blog: Mylan, Apotex, and Teva File Mot...
RealClearPolitics - Articles - DNA Denied, Justice...
Early Examples of Biotechnology
IndustryWeek : Abbott Opens New Biotechnology Manu...
California Stem Cell Report
VentureBeat � Is Big Pharma tiptoeing into embryon...
Micro RNAs: The Last Frontier of Medicine?
Pharma Sales Reps Suing for Overtime: $1 Billion P...
Logo Design Blog � Biotechnology Logos
TCS Daily - The Angel Is in the Details
Health Affairs Blog
Biotech seeks to ease fuel's reliance on oil, corn...
Biotech firms should keep it simple
SignOnSanDiego.com > News > Business > Biotechnolo...
BioWorld Today
New biotech company to commercialize novel UD gene...
Farmer Success Stories from around the World from ...
California Healthcare Institute Submits Statement ...
Terry Etherton Blog on Biotechnology � Ben & Jerry...
Large Numbers of People Do Not Trust the Instituti...
Baxter Announces Carbon Neutral Headquarters
Avicena's Huntington's Disease Drug Candidate Sele...
Onconome Announces Completion of Breakthrough Rese...
Press Release: Merck's Singulair Wins New Asthma I...
Scientists Identify Pathogens That May Be Causing ...
Press Release: Biotech Drug Spending Increases 21 ...
Kansas City infoZine News - Corn Growers Urge Care...
Pharmalot: Kennedy Circulates Biogenerics Bill
Xenoport Sees Positive Study Data - Forbes.com
News: Celera Licenses Oncology-Related Discoveries...
News: Researchers Link Gene Variations to AMD Prog...
Biotech start-ups flush from big venture rounds - ...
Patent Prospector: Junk Patents
FDA to investigate Lilly's handling of Zyprexa dat...
Biotech contenders - baltimoresun.com
Health Blog : Glaxo's Garnier on MedImmune, Pipeli...
Out of the Gate: BioDelivery Sciences Up - Forbes.com
Pfizer Subsidiary Pleads Guilty to Kickback Violat...
The Energy Blog: Mirel Bioplastic Plant Announced ...
Writers Wanted
evolgen: Junk DNA in Scientific American
Jumping 'Junk' DNA May Fuel Mammalian Evolution: S...
Dendreon: An Even Better Risk vs. Reward Scenario ...
Truth About Trade & Technology - Island Matters
Glaxo's Sales Drop as Patents Expire, Guides Upbea...
Health Blog : A Strong Season for Vaccines
7 Companies Searching to Treat or Cure Parkinson's...
USA for Innovation's 8 Deadly Lies About Thailand'...
North Jersey Media Group providing local news, spo...
Patent Docs: Patent Profile: SinoBiomed Announces ...
Dyadic investigating potential improprieties, stoc...
The Manila Times Internet Edition | OPINION >